Jeyanesh Tambiah, MBChB

Genascence Corporation
San Diego, California, United States

Chief Medical Officer

Presentation(s):

• 0310: Evaluate Safety, Tolerability, and Pharmacodynamics of a Single Intra-Articular Injection of GNSC-001 Gene Therapy in Subjects with Knee Osteoarthritis: 12-month Results from DONATELLO

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Genascence: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)